Cytomegalovirus infection enhances the neointima formation in rat aortic allografts: Effect of major histocompatibility complex class I and class II antigen differences

Transplantation

Volumn 65, Issue 10, 1998, Pages 1298-1304

  Li, Fengling ^a   Yin, Ming ^a   Van Dam, Joanne G ^a   Grauls, Gert ^a   Rozing, Jan ^b   Bruggeman, Cathrien A ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; AORTITIS; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; MALE; MUROMEGALOVIRUS; RATS; RATS, INBRED STRAINS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 0032571999     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805270-00003     Document Type: Article

References (45)

1. Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11 (3 Pt 2): S38.
2. Hosenpud JD, Hershberger RE, Ratkovec RR, et al. Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection. J Heart Lung Transplant 1992; 11 (4 Pt 1): 739.
3. Gao SZ, Hunt SA, Schroeder JS, Alderman EL, Hill IR, Stinson EB. Early development of accelerated graft coronary artery disease: risk factors and course. J Am Coll Cardiol 1996; 28: 673.
4. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation - rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244.
5. Hayry P, Mennander A, Raisanen A, et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev 1993; 7: 1.
6. Hayry P, Myllarniemi M, Aavik E. Chronic allograft rejection. Transplant Proc 1996; 28: 2337.
7. Cramer DV, Qian SQ, Harnaha J, et al. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation 1989; 47: 414.
8. Grattan MT, Moreno Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
9. Loebe M, Schuler S, Spiegelsberger S, Warnecke H, Fleck E, Hetzer R. Cytomegalovirus infection and coronary sclerosis after heart transplantation. Dtsch Med Wochenschr 1990; 115: 1266.
10. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359.
11. Weimar W, Balk AH, Metselaar HJ, Mochtar B, Rothbarth PH. On the relation between cytomegalovirus infection and rejection after heart transplantation. Transplantation 1991; 52: 162.
12. Scott CD, Colquhoun IW, Gould K, Au J, Dark JD. Determinants of graft arteriosclerosis after heart transplantation. Transpl Int 1992; 5: S238.
13. Bruggeman CA, Meijer H, Bosman F, van Boven CP. Biology of rat cytomegalovirus infection. Intervirology 1985; 24: 1.
14. Steinhoff G, You XM, Steinmuller C, et al. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat. Transplantation 1996; 61: 1250.
15. Steinhoff G, You XM, Steinmuller C, et al. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat. Scand J Infect Dis Suppl 1995; 99: 58.
16. Martelius T, Krogerus L, Hockerstedt K, Makisalo H, Bruggeman C, Lautenschlager I. CMV causes bile duct destruction and arterial lesions in rat liver allografts. Transplant Proc 1997; 29(1-2): 796.
17. Lautenschlager I, Soots A, Krogerus L, et al. CMV increases inflammation and accelerates chronic rejection in rat kidney allografts. Transplant Proc 1997; 29: 802.
18. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Hayry P. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler Thromb 1991; 11: 671.
19. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993; 92: 549.
20. Lemstrom KB, Bruning JH, Bruggeman CA, Lautenschlager IT, Hayry PJ. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am J Pathol 1994; 144: 1334
21. Bruning JH, Persoons M, Lemstrom K, Stals FS, Clerq de E, Bruggeman CA. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by anti viral therapy in the form of HPMPC. Transpl Int 1994; 7 (suppl): S365
22. Li F, Grauls G, Yin M, Bruggeman C. Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts. Transpl Int 1996; 9 (suppl): S340.
23. Cray C, Levy RB. The ability of murine cytomegalovirus and class I major histocompatibility complex-disparate parental cells to induce alterations characteristic of severe graft-versus-host reactions. Transplantation 1989; 48: 1057.
24. Cray C, Levy RB. CD8+ and CD4+ T cells contribute to the exacerbation of class I MHC disparate graft-vs-host reaction by concurrent murine cytomegalovirus infection. Clin Immunol Immunopathol 1993; 67: 84.
25. Li F, Grauls G, Yin M, Bruggeman CA. Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis. Transplant Proc 1995; 27: 3552.
26. Joly E, Deverson EV, Coadwell JW, Gunther E, Howard JC, Butcher GW. The distribution of Tap2 alleles among laboratory rat RT1 haplotypes. Immunogenetics 1994; 40(1): 45.
27. Vaessen LMB, Hameijer LDF, Carpenter CB, Cramer DV, Rozing J. The R1-rat: a new RT1 haplotype. Transplant Proc 1979: 11: 1565.
28. Bruggeman CA, Debie WM, Grauls G, Majoor G, van Boven CP. Infection of laboratory rats with a new cytomegalo-like virus. Arch Virol 1983; 76: 189.
29. Stals FS, Bosman F, van Boven CP, Bruggeman CA. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol 1990; 114: 91.
30. Bruning JH, Debie WH, Dormans PH, Meijer H, Bruggeman CA. The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens. Arch Virol 1987; 94: 55.
31. Li F, Grauls G, van Dam JG, Yin M, Bruggeman CA. Cytomegalovirus infection enhances the perivascular inflammatory reaction in transplanted aortic allografts. Cardiovasc Eng 1997; 2: 207.
32. Michelson S. Interaction of human cytomegalovirus with monocytes/macrophages: a love-hate relationship. Pathol Biol 1997; 45: 146.
33. Cramer D, Chapman F, Wu G, Harnaha J, Qian S, Makowka L. Cardiac transplantation in the rat. II Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation 1990; 50: 554.
34. Akyurek L, Paul L, Funa C, Larsson E, Fellstrom B. Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy. Transplantation 1996; 62: 1526.
35. Steinmuller C, Steinhoff G, Bauer D, et al. Analysis of leukocyte activation during acute rejection of pulmonary allografts in noninfected and cytomegalovirus-infected rats. J Leukoc Biol 1997; 61: 40.
36. Azuma H, Nadeau KC, Ishibashi M, Tilney NL. Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 1995; 60: 1577.
37. Via CS, Shanley JD, Shearer GM. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only: analysis of in vitro T cell function. J Immunol 1990; 145: 3283.
38. Yamashiroya HM, Ghosh L, Yang R, Robertson AL Jr. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988; 130: 71.
39. Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23.
40. Yang H, Welsh RM. Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol 1986; 136: 1186.
41. Shanley JD, Via CS, Sharrow SO, Shearer GM. Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction: characterization of bronchoalveolar lavage cells. Transplantation 1987; 44: 658.
42. Grundy JE, Shanley JD, Shearer GM. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 1985; 39: 548.
43. Lemstrom KB, Aho PT, Bruggeman CA, Hayry PJ. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts: possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler Thromb 1994; 14: 2043.
44. Koskinen PK. The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Transplantation 1993; 56: 1103.
45. Lautenschlager I, Hockerstedt K. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection. Transplant Proc 1993; 25 (1 Pt 2): 1429.